Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Pharming (PHAR) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Pharming (PHAR) over the last 3 years, with Q2 2023 value amounting to 133.31%.

  • Pharming's Return on Invested Capital changed N/A to 133.31% in Q2 2023 from the same period last year, while for Jun 2023 it was 133.31%, marking a year-over-year change of. This contributed to the annual value of 23.98% for FY2021, which is 465337100.0% up from last year.
  • Pharming's Return on Invested Capital amounted to 133.31% in Q2 2023.
  • In the past 5 years, Pharming's Return on Invested Capital ranged from a high of 183.65% in Q2 2021 and a low of 11.93% during Q4 2021
  • Over the past 3 years, Pharming's median Return on Invested Capital value was 56.42% (recorded in 2021), while the average stood at 77.05%.
  • The largest annual percentage gain for Pharming's Return on Invested Capital in the last 5 years was 151700bps (2022), contrasted with its biggest fall of -651800bps (2022).
  • Quarter analysis of 3 years shows Pharming's Return on Invested Capital stood at 11.93% in 2021, then skyrocketed by 127bps to 27.09% in 2022, then surged by 392bps to 133.31% in 2023.
  • Its Return on Invested Capital stands at 133.31% for Q2 2023, versus 27.09% for Q4 2022 and 20.57% for Q3 2022.